BioLife Solutions, Inc. Repayments of Other Long-term Debt
BioLife Solutions, Inc. (BLFS) reported Repayments of Other Long-term Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2026-02-26
- BioLife Solutions, Inc. repayments of other long-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. repayments of other long-term debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. repayments of other long-term debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. repayments of other long-term debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. repayments of other long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BioLife Solutions, Inc. repayments of other long-term debt for fiscal 2024 was $1.61M, a 712.12% increase from fiscal 2023.
- BioLife Solutions, Inc. repayments of other long-term debt for fiscal 2023 was $198.00K, a 60.24% decline from fiscal 2022.
- BioLife Solutions, Inc. repayments of other long-term debt for fiscal 2022 was $498.00K, a 132.71% increase from fiscal 2021.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $926.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $926.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $926.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.14M derived: sum of 3 quarters · filed 2026-02-26 | $1.37M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.14M derived: sum of 2 quarters · filed 2026-02-26 | $1.37M derived: sum of 3 quarters · filed 2026-02-26 | $1.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $441.00K derived: sum of 2 quarters · filed 2025-11-06 | $682.00K 10-Q · filed 2025-11-06 | $497.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $468.00K 10-Q · filed 2025-08-07 | $283.00K derived: sum of 3 quarters · filed 2026-02-26 | $410.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $241.00K 10-Q · filed 2025-05-08 | $56.00K derived: sum of 2 quarters · filed 2026-02-26 | $183.00K derived: sum of 3 quarters · filed 2026-02-26 | $312.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$58.00K derived: sum of 2 quarters · filed 2026-02-26 | $71.00K derived: sum of 3 quarters · filed 2026-02-26 | $198.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $256.00K derived: sum of 2 quarters · filed 2024-11-12 | $383.00K 10-Q · filed 2024-11-12 | $511.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $256.00K 10-Q · filed 2024-08-09 | $384.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2023-03-31 | $127.00K 10-Q · filed 2024-05-10 | $255.00K derived: sum of 2 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $498.00K 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $370.00K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $214.00K 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |